Journal of Environmental Pathology Toxicology and Oncology

Papers
(The median citation count of Journal of Environmental Pathology Toxicology and Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Construction of a Liver Cancer Prognostic Model Based on Interferon-Gamma-Related Genes for Revealing the Immune Landscape46
Treatment Strategy for Breast Benign Intraductal Papilloma: A Meta-Analysis41
Correlation of FBXO45 Expression Levels with Cancer Severity by ZEB1 Ubiquitin in Non-Small-Cell Lung Cancer17
The Long Non-Coding RNA linc01105 Inhibits Gastric Cancer Growth and Metastasis by Regulating the miR-650/TCEA3 Axis16
15
Biochemical Ferrous Ions (Fe2+) Mediated Fenton Reaction: A Biological Prodigy for Curing and Developing Autoimmune Rheumatoid Arthritis and Cancer9
A Review on Protease Inhibitors of Herbal Origin to Combat Malignancy8
Analysis of the Clinical Value of hsa_circ_0001955 in Papillary Thyroid Cancer Treated with 131 Iodine8
Complex Genomic Rearrangement Patterns in Malignant Pleural Mesothelioma due to Environmental Asbestos Exposure6
Ethyl Acetate Extract of Oratosquilla Inhibits the Growth of Nasopharyngeal Carcinoma through the Hippo Pathway6
miR-125b-5p Suppresses Leukemia Cell Proliferation by Regulating MCL16
Molecular Pathogenesis, Organ Metastasis, and Targeted Therapy for Non-Small-Cell Lung Cancer6
Comprehensive Investigation of m6A Regulators for Prognosis in Head and Neck Squamous Cell Carcinoma6
Identification of Lung Adenocarcinoma Subtypes Using Growth Hormone-Releasing Hormone-Related Genes and Establishment of Signature to Predict Prognosis and Guide Immunotherapy5
Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer5
PRMT4 Reduced Erastin-Induced Ferroptosis in Nasopharyngeal Carcinoma Cisplatin-Resistant Cells by Nrf2/GPX4 Pathway5
5
Histone-Lysine N-Methyltransferase 2D (KMT2D) Impending Therapeutic Target for the Management of Cancer: The Giant Rats Tail4
A Systems Biology Approach Unveils a Critical Role of DPP4 in Upper Gastrointestinal Cancer Patient Outcomes4
Expression Profiles, Prognosis, and ceRNA Regulation of SRY-Related HMG-Box Genes in Stomach Adenocarcinoma4
Comprehensive Characterization of Crotonylation-Related lncRNAs Reveals a Prognostic Signature and Functional Landscape in Bladder Cancer4
Exploring the Mechanical Perspective of a New Anti-Tumor Agent: Melatonin4
Histone Methyltransferase EHMT2 Promotes the Progression of Breast Ductal Carcinoma by Regulating the Hippo Pathway4
Expression and Significance of the Long Non-Coding RNA APTR in the Occurrence and Development of Lung Adenocarcinoma4
4
4
Studies on the Therapeutic and Prognostic Biomarkers of Glioma Using a Novel Cuproptosis-Related IncRNA Signature and Validation in Glioma4
A Review on Experimentally Proven Medicinal Plants and Their Constituents against Fluoride Toxicity4
Elucidating the Molecular Mechanisms of N-Nitrosodimethylamine-Induced Colorectal Cancer: A Network Toxicology and Molecular Docking Analysis4
PA2G4P4 Promotes Glioma Cell Migration and Tumorigenesis through the PTEN/AKT/mTOR Signaling Pathway4
Index, Volume 44, 20253
Identification of Ion Channel-Associated Prognostic Biomarkers for Lung Adenocarcinoma3
Anti-Cancer Role of Ellagic Acid by Modulating the Altered PI3K/PTEN/Akt Pathway in Bladder Cancer3
Prediction of Prognosis, Tumor Microenvironment, and Drug Treatment of Colorectal Cancer Based on Retinoic Acid-Related Genes3
Silencing the lncRNA EBLN3P Improves Prognosis in Patients with Invasive Breast Cancer by Directly Targeting miR-144-3p3
Gene Variations of Chemokine and Chemokine Receptor CXCL12/CXCR4 in Lung Cancer2
Chemotherapeutic Drugs Endow Gastric Cancer Mesenchymal Stem Cells with Stronger Tumor-Promoting Ability2
2
INDEX2
Transcription Factor E2F1 Enhances Hepatocellular Carcinoma Cell Proliferation and Stemness by Activating GINS12
PFKFB3 Regulates the Growth and Migration of Ovarian Cancer Cells through Pyroptosis and Warburg Effect Progression2
Bioinformatics Unveils Key Genes in the MAPK Pathway in Colorectal Cancer and Predicts Prognosis, Immune Characteristics, and Potential Drugs2
lncRNA-miRNA/RBP-mRNA Network Involved in Human Triple-Negative Breast Cancer: An Integrated Approach2
METTL14 Promotes Oral Squamous Cell Carcinoma Progression by Regulating the mRNA and m6A Levels of CALD12
Recent Developments and Challenges in Molecular-Targeted Therapy of Non-Small-Cell Lung Cancer1
Downregulation of miR-605-5p Facilitates Breast Cancer Progression and Predicts Unfavorable Prognosis1
Differential microRNAs Expression during Cancer Development, and Chemoprevention by Natural Compounds: A Comprehensive Review1
1
Inhibition of Interleukin-1 Receptor-Associated Kinase-1 by Pacritinib Is a Therapeutic Strategy to Overcome Melanoma Resistance1
lncRNA FENDRR as a Prognostic Biomarker and Regulator of Bladder Cancer Progression via the miR-18a-5p/ESR1 Axis1
Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis1
lncRNA AGAP11 Suppresses Lung Adenocarcinoma Progression by miR-494-3p and Predicts Prognosis1
1
lncRNA PTCSC1 Promotes TRAIL Resistance through FOXO3a Pathway in HCT116 and SW480 Cells1
Frequency of Healthy Control Genotype of VDR Gene Polymorphisms in the Saudi Population of the Ha'il Region: A Comparative Study with Worldwide Population1
Antitumor Effect of 5-Aminolevulinic Acid Methyl Ester-Mediated Photodynamic Therapy on Local Skin Melanoma and Its Metastasized Tumor, in Relation with Antitumor Immunity1
LncRNA LINC01278 Regulates the Prognosis and Related Mechanisms of Gastric Cancer by Targeting miR-129-5p1
1
0.023294925689697